Pucciarelli G, De Vecchis R, Ebraio F, Corigliano G G
Servizio di Cardiologia, Day Hospital Elena D'Aosta, Napoli.
Cardiologia. 1997 Jul;42(7):721-7.
In 17 patients suffering from recurrent episodes of vasovagal syncope as well as in 21 healthy subjects without clinical episodes of presyncope or syncope, we evaluated the reflex decrease in heart rate evoked by the phenilephrine test. In the syncopal patients, the measurements were taken 4-12 hours after the clinical appearance of syncope. We divided the syncopal patients as follows: 9 patients, undergoing pharmacological treatment, and 8 untreated patients (drug free arm). In the pharmacological arm of the study, an alternate, randomized administration of metoprolol (150 mg twice daily for 2 days) and verapamil (80 mg every 6 hours for 2 days) was provided. Therefore, in the pharmacological arm as well as in drug free patients, we tested again the baroreflex sensitivity, by means of iv phenilephrine bolus, 3 and 7 days after the clinical appearance of the syncopal event. The baroreflex sensitivity values were significantly higher in the syncopal group compared to the control group (21 +/- 5 vs 13 +/- 4.5 ms/mm Hg; p < 0.01). Of the two tested drugs, only the metoprolol produced a fast (day 3) decrease in baroreflex sensitivity. On the basis of measurements taken after 7 days, we noted a pattern of widespread reduction in baroreflex sensitivity values, found in both treated and untreated patients. In conclusion, patients with vasovagal syncope exhibited a more pronounced maximal parasympathetic activation compared to the control group. The high baroreflex sensitivity values were soon (day 3) reduced by metoprolol, but not by verapamil therapy; a spontaneous normalization in baroreflex sensitivity values was found 7 days after the clinical episode, regardless of therapy.
在17例患有反复发作血管迷走性晕厥的患者以及21例无晕厥前期或晕厥临床发作的健康受试者中,我们评估了苯肾上腺素试验诱发的心率反射性下降。在晕厥患者中,测量在晕厥临床发作后4 - 12小时进行。我们将晕厥患者分为以下两组:9例接受药物治疗的患者,以及8例未治疗的患者(无药物组)。在该研究的药物治疗组中,交替随机给予美托洛尔(每日两次,每次150 mg,共2天)和维拉帕米(每6小时80 mg,共2天)。因此,在药物治疗组以及无药物组患者中,我们在晕厥事件临床发作后3天和7天通过静脉注射苯肾上腺素推注再次测试压力反射敏感性。与对照组相比,晕厥组的压力反射敏感性值显著更高(21±5 vs 13±4.5 ms/mm Hg;p < 0.01)。在两种测试药物中,只有美托洛尔使压力反射敏感性迅速(第3天)下降。根据7天后的测量结果,我们注意到在治疗组和未治疗组患者中均出现压力反射敏感性值普遍降低的模式。总之,与对照组相比,血管迷走性晕厥患者表现出更明显的最大副交感神经激活。美托洛尔可使高压力反射敏感性值迅速(第3天)降低,但维拉帕米治疗则无此效果;临床发作7天后,无论是否接受治疗,压力反射敏感性值均出现自发正常化。